Eko Analysis Software vs qXR-CTR
AI Verdict
Choose Eko Analysis Software if…
Choose Eko Analysis Software if your primary need is real-time, AI-assisted auscultation and detailed analysis of heart sounds and ECGs during patient encounters or remote monitoring. This tool is ideal for clinicians seeking early detection of heart murmurs and atrial fibrillation directly from a digital stethoscope, with capabilities for recording, playback, and secure storage of cardiac data.
View Eko Analysis Software →Choose qXR-CTR if…
Choose qXR-CTR if your focus is on automating the measurement of the cardiothoracic ratio from chest X-ray images to quickly assess heart size and potential heart failure risk. This solution is best suited for radiology departments or clinical settings that regularly utilize chest X-rays and require an efficient, AI-powered tool to streamline the identification of cardiomegaly.
View qXR-CTR →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Analysis Software | qXR-CTR |
|---|---|---|
| Pricing | Freemium with subscription for full features | Unknown |
| Deployment | Cloud-based | Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Analysis SoftwareEko Analysis Software (Tool A) integrates with a mobile app and digital stethoscopes, offering a direct and interactive experience for clinicians at the point of care. Its freemium model also suggests a lower barrier to entry for individual users, promoting ease of adoption and a user-friendly interface.
Clinical Value
Eko Analysis SoftwareWhile both tools are FDA-cleared and address significant cardiovascular needs, Eko Analysis Software (Tool A) offers a broader range of real-time diagnostic assistance for common conditions like heart murmurs and AFib directly during auscultation. This immediate, point-of-care feedback can lead to earlier detection and intervention across various clinical settings.
Pricing & Value
Eko Analysis SoftwareEko Analysis Software (Tool A) employs a transparent freemium model, allowing users to experience basic features before committing to a subscription for full AI capabilities. In contrast, qXR-CTR (Tool B) requires contacting for pricing, which lacks transparency and makes it difficult for potential users to assess its value proposition upfront.
Enterprise Readiness
qXR-CTRqXR-CTR (Tool B) offers flexible deployment options including cloud, on-premise, and hybrid, which is crucial for large healthcare enterprises with diverse IT infrastructures and data residency requirements. Eko Analysis Software (Tool A) is primarily cloud-based, offering less flexibility for complex enterprise environments.
Innovation
Eko Analysis SoftwareEko Analysis Software (Tool A) demonstrates greater innovation by integrating AI directly with a physical diagnostic device (digital stethoscope) for real-time, point-of-care analysis. This approach offers a novel way to augment clinical decision-making at the moment of patient interaction, distinguishing it from automated image analysis, which is a more established application of AI in healthcare.
Support & Docs
Eko Analysis SoftwareEko Analysis Software (Tool A) provides comprehensive and clearly segmented support, including a dedicated Help Center for individual customers and a separate SENSORAu2122 Help Center for enterprise institutions. This structured approach, along with extensive public documentation and direct support channels, indicates a robust and accessible support ecosystem.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Analysis Software | qXR-CTR |
|---|---|---|
| Primary Function | Assists clinicians in the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation, integrating with digital stethoscopes and a mobile app. | Automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk. |
| Company | Eko Devices | Qure.ai Technologies |
| Key AI Detections/Functions | FDA-cleared AI for heart murmur detection; FDA-cleared AI for atrial fibrillation (AFib) detection; Detection of normal sinus rhythm; Calculation of cardiac time intervals; Wireless auscultation; Recording, playback, and annotation of heart sounds and ECGs; Visualization of phonocardiograms (PCG) and ECG tracings; Secure cloud-based storage. | Automated measurement of cardiothoracic ratio (CTR) from chest X-ray images. |
| Categories | Cardiology AI, Wearables & Remote Monitoring (RPM) | Cardiology AI, Radiology & Imaging AI |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Eko Analysis Software and qXR-CTR.